As indicated by the results, the transcriptional levels of EGR1, EGR2, and EGR3 were significantly reduced in patients with BRCA (p < 0.05), whereas the expression level of EGR4 was very low in both breast cancer and normal breast tissues (Figure 1A). This evidence concerns the gene EGR2 and breast cancer.